⌘K

Login Start Free

Home/Filings/4/0001213900-24-051414

4//SEC Filing

Nolet Chris 4

Accession 0001213900-24-051414

CIK 0001788028other

View on SEC.gov Company Profile

Filed

Jun 9, 8:00 PM ET

Accepted

Jun 10, 6:28 PM ET

Size

11.8 KB

Accession

0001213900-24-051414

Insider Transaction Report

Form 4

Period: 2024-06-06

Jasper Therapeutics, Inc.JSPR

Director

Transactions

Award
Stock Option (right to buy)
2024-06-06+7,500→ 7,500 total
Exercise: $25.41From: 2025-06-06Exp: 2034-06-06→ Voting Common Stock (7,500 underlying)

Documents

2 files

Issuer

Jasper Therapeutics, Inc.

CIK 0001788028

Entity typeother

Related Parties

1

filerCIK 0001782814

Filing Metadata

Form type: 4
Filed: Jun 9, 8:00 PM ET
Accepted: Jun 10, 6:28 PM ET
Size: 11.8 KB

View on SEC.gov